There are no known direct interactions between Replenza and injectable GLP-1 medications like semaglutide or tirzepatide
For example, medical conditions were self-reported, whereas Bessette and Anderson were unable to measure all trial exclusion criteria with accurate temporality, which may underestimate the proportion excluded. Bessette said that primary care providers should consider screening for depression, liver function, and concomitant use of medications that delay gastric emptying before prescribing medications like GLP-1 receptor agonists
This aspect is particularly noteworthy, as fasting intervals promote lipolysisthe degradation of fat reservesand elevate fatty acid oxidation [15]
The complete switching guide covers the full transition process
And when you take it again, youre going to have that side effect again because there hasnt been a steady amount of the medication in your system. Accidental overdosing is another potential risk of microdosing GLP-1s, especially if youre using a compounded version
The key is working with the appetite suppression rather than against it